Hep C News

U.S. FDA Updates on Hepatitis C Treatment Drugs

FacebookTwitterLinkedInEmailPrint

The U.S. FDA released November 13, 2017 new updates on Hepatitis C treatment medications.   The Sovaldi (sofosbuvir), Harvoni (ledipasvir and sofosbuvir), Epclusa (sofosbuvir and velpatasvir) and Vosevi (sofosbuvir, velpatasvir, and voxilaprevir) labels were updated to include information pertaining to changes in International Normalized Ratio (INR) values in patients receiving warfarin.   Section 7: DRUG …

HealthCare News Newspaper roll with white background
Continue Reading »

Mislabeled Dietary Supplements May Cause Liver Damage

FacebookTwitterLinkedInEmailPrint

The AASLD (American Association for the Study of Liver Disease) recently reported at this year’s 2017 Liver Meeting, “Mislabeling or omission of ingredients occurs frequently in herbal and dietary supplements, especially among bodybuilding and weight loss products.”   Herbal and dietary supplements that have not gone through vital testing, clinical trial studies and not under …

.
Continue Reading »

FDA Approves New Hepatitis C Treatment Mavyret for All Genotypes

FacebookTwitterLinkedInEmailPrint

The U.S. FDA approved Hepatitis C treatment Mavyret, for all genotypes, for patients without cirrhosis and those with compensated cirrhosis as well as patients with genotype 1 who have been previously treated with an HCV NS5A inhibitor or NS3/4A protease inhibitor but not both and for patients with severe kidney disease, including those on dialysis. …

HealthCare News Newspaper roll with white background
Continue Reading »